Aarti Pharmalabs Limited has informed the Exchange about Copy of Newspaper Publication
AARTIPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aarti Pharmalabs has submitted copies of newspaper publications of its Standalone and Consolidated Audited Financial Results for the quarter and financial year ended March 31, 2025, to BSE and NSE. The results were published in Financial Express (English) and Loksatta–Jansatta (Gujarati) on May 12, 2025. This filing is made under Regulation 30 and 47 of SEBI's Listing Obligations and Disclosure Requirements Regulations, 2015. The submission is a routine compliance requirement and does not contain new financial information beyond what was already reported. Signed by Jeevan Mondkar, Company Secretary and Legal Head of the company.
No direct impact on shareholders or stock price — this is a standard regulatory disclosure confirming that audited Q4 and FY25 results have been published in newspapers as required by SEBI rules.